G. Abou-Mohamed

1.0k total citations
23 papers, 873 citations indexed

About

G. Abou-Mohamed is a scholar working on Physiology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, G. Abou-Mohamed has authored 23 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 7 papers in Cellular and Molecular Neuroscience and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in G. Abou-Mohamed's work include Nitric Oxide and Endothelin Effects (15 papers), Cardiac Ischemia and Reperfusion (4 papers) and Neuropeptides and Animal Physiology (4 papers). G. Abou-Mohamed is often cited by papers focused on Nitric Oxide and Endothelin Effects (15 papers), Cardiac Ischemia and Reperfusion (4 papers) and Neuropeptides and Animal Physiology (4 papers). G. Abou-Mohamed collaborates with scholars based in United States, Czechia and Egypt. G. Abou-Mohamed's co-authors include Robert W. Caldwell, Ruth B. Caldwell, Azza B. El‐Remessy, John D. Catravas, M. Ali Behzadian, Andreas Papapetropoulos, Gregory I. Liou, Keith Green, Suraporn Matragoon and Penny Roon and has published in prestigious journals such as Journal of the American College of Cardiology, American Journal Of Pathology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

G. Abou-Mohamed

23 papers receiving 858 citations

Peers

G. Abou-Mohamed
Omorodola I. Abatan United States
Valeriy V. Lyzogubov United States
Modesto Rojas United States
Hae Sook Noh South Korea
Alexander Obrosov United States
Jerry G. Webb United States
Kenneth E. Eakins United States
Omorodola I. Abatan United States
G. Abou-Mohamed
Citations per year, relative to G. Abou-Mohamed G. Abou-Mohamed (= 1×) peers Omorodola I. Abatan

Countries citing papers authored by G. Abou-Mohamed

Since Specialization
Citations

This map shows the geographic impact of G. Abou-Mohamed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Abou-Mohamed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Abou-Mohamed more than expected).

Fields of papers citing papers by G. Abou-Mohamed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Abou-Mohamed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Abou-Mohamed. The network helps show where G. Abou-Mohamed may publish in the future.

Co-authorship network of co-authors of G. Abou-Mohamed

This figure shows the co-authorship network connecting the top 25 collaborators of G. Abou-Mohamed. A scholar is included among the top collaborators of G. Abou-Mohamed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Abou-Mohamed. G. Abou-Mohamed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abou-Mohamed, G., J. A. Johnson, Liming Jin, et al.. (2004). Roles of Superoxide, Peroxynitrite, and Protein Kinase C in the Development of Tolerance to Nitroglycerin. Journal of Pharmacology and Experimental Therapeutics. 308(1). 289–299. 44 indexed citations
2.
El‐Remessy, Azza B., Suraporn Matragoon, G. Abou-Mohamed, et al.. (2003). Neuroprotective Effect of(−)Δ9-Tetrahydrocannabinol and Cannabidiol in N-Methyl-d-Aspartate-Induced Retinal Neurotoxicity. American Journal Of Pathology. 163(5). 1997–2008. 196 indexed citations
3.
Abou-Mohamed, G., Ahmed A. Elmarakby, Gerald O. Carrier, et al.. (2003). Estradiol Relaxes Rat Aorta via Endothelium-Dependent and -Independent Mechanisms. Pharmacology. 69(1). 20–26. 14 indexed citations
5.
Abou-Mohamed, G., et al.. (2002). Peroxynitrite (ONOO-) Increases Vascular Permeability in Experimental Diabetes by a Mechanism Involving Increased Expression of Urokinase Plasminogen Activator Receptor (uPAR). Investigative Ophthalmology & Visual Science. 43(13). 1308–1308. 2 indexed citations
6.
Badria, Farid A., et al.. (2001). Mirazid: A New Schistosomicidal Drug. Pharmaceutical Biology. 39(2). 127–131. 35 indexed citations
7.
Abou-Mohamed, G., Jianzhong Huang, Liming Jin, et al.. (2000). Vascular and Endothelial Actions of Inhibitors of Substance P Amidation. Journal of Cardiovascular Pharmacology. 35(6). 871–880. 7 indexed citations
8.
Abou-Mohamed, G., Wayne Kaesemeyer, Ruth B. Caldwell, & Robert W. Caldwell. (2000). Role of L‐arginine in the vascular actions and development of tolerance to nitroglycerin. British Journal of Pharmacology. 130(2). 211–218. 52 indexed citations
9.
Abou-Mohamed, G., Andreas Papapetropoulos, John D. Catravas, & Robert W. Caldwell. (1998). Zn2+ inhibits nitric oxide formation in response to lipopolysaccharides: Implication in its anti-inflammatory activity. European Journal of Pharmacology. 341(2-3). 265–272. 44 indexed citations
10.
El‐Mowafy, Abdalla M. & G. Abou-Mohamed. (1997). NON-EPITHELIAL ENDOTHELIN-A RECEPTORS ACTIVATE ADENYLATE CYCLASE IN RAT TRACHEA: BIOCHEMICAL MECHANISMS AND PHYSIOLOGICAL IMPLICATIONS. Life Sciences. 61(15). 1529–1538. 4 indexed citations
11.
Abou-Mohamed, G., Wayne Kaesemeyer, Andreas Papapetropoulos, John D. Catravas, & R. William Caldwell. (1996). Nitroglycerin (NTG), but not sodium nitroprusside (SNP), increases vascular cGMP levels via an L-arginine dependent and L-NAME sensitive pathway. Journal of the American College of Cardiology. 27(2). 105–105. 2 indexed citations
12.
Abou-Mohamed, G., et al.. (1996). Characterization of the adrenergic activity of arbutamine, a novel agent for pharmacological stress testing. Cardiovascular Drugs and Therapy. 10(1). 39–47. 6 indexed citations
13.
El‐Mowafy, Abdalla M. & G. Abou-Mohamed. (1996). Endothelins‐induce cyclicAMP formation in the guinea‐pig trachea through an ETA receptor‐ and cyclooxygenase‐dependent mechanism. British Journal of Pharmacology. 118(3). 531–536. 10 indexed citations
14.
Papapetropoulos, Andreas, G. Abou-Mohamed, Nándor Marczin, et al.. (1996). Downregulation of nitrovasodilator‐induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin‐1β. British Journal of Pharmacology. 118(6). 1359–1366. 73 indexed citations
15.
Abou-Mohamed, G., et al.. (1996). A novel catecholamine, arbutamine, for a pharmacological cardiac stress agent. Cardiovascular Drugs and Therapy. 10(1). 31–38. 3 indexed citations
16.
Abou-Mohamed, G.. (1996). L-arginine in the development and reversal of tolerance to nitroglycerin. American Journal of Hypertension. 9(4). 33A–33A. 3 indexed citations
17.
Abou-Mohamed, G., et al.. (1995). Effect of Zinc on the Anti-Inflammatory and Ulcerogenic Activities of Indometacin and Diclofenac. Pharmacology. 50(4). 266–272. 14 indexed citations
18.
Abou-Mohamed, G., Andreas Papapetropoulos, Dietmar Ulrich, et al.. (1995). HP-228, a novel synthetic peptide, inhibits the induction of nitric oxide synthase in vivo but not in vitro.. Journal of Pharmacology and Experimental Therapeutics. 275(2). 584–591. 27 indexed citations
19.
Abou-Mohamed, G., Robert W. Caldwell, Gerald O. Carrier, Mohamed M. Elmazar, & Ronald R. Tuttle. (1994). Interactions of a Novel Catecholamine, GP-2-128, with Adrenoceptors. Journal of Cardiovascular Pharmacology. 23(3). 492–500. 4 indexed citations
20.
Abou-Mohamed, G., Robert W. Caldwell, Tarek M. Ibrahim, & Ronald R. Tuttle. (1994). Integrative Cardiovascular Actions of a Novel Catecholamine, GP-2-128. Journal of Cardiovascular Pharmacology. 23(3). 485–491. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026